Concept
Research Funding
Cancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute / What the Report Means for Immunotherapy
"Protect research funding: The report warns that continued progress is threatened by proposed federal cuts to cancer research and health insurance. Advances in immunotherapy are the result of decades of investment in foundational scientific research–and future breakthroughs will be impossible without the same long-term commitment. The stakes couldn’t be higher: cutting research funding now would halt progress precisely when patients need it most."
Related Ideas
- Research ProgressCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · The Road Ahead
- Equal AccessCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · The Road Ahead
- Immunotherapy ReachCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · What the Report Means for Immunotherapy
- Survival GainsCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Immunotherapy Is Helping Rewrite Survival Curves
- Cancer ProgressCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Progress Is Real, But Uneven
- Drug DevelopmentFuture of Cancer Science | AACR Cancer Progress Report 2025 · Drug Development
- Cancer ImmunotherapyCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Introducing CRI’s 2025 Cancer Immunotherapy Insights + Impact Report: Evolution of Immunotherapy, FDA Approvals & Next-Generation Treatment Trends
- Cancer ChallengesCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · The Road Ahead